Loading...
Loading...
Indian Pharmaceutical Exporter Β· #11 for Sofosbuvir Β· $124.8K export value Β· DGFT Verified
Galaxy Super Speciality is the #11 Indian exporter of Sofosbuvir with $124.8K in export value and 38 verified shipments. Galaxy Super Speciality holds a 0.3% market share in Sofosbuvir exports across 7 countries. The company exports 7 pharmaceutical products worth $240.3K across 3 therapeutic categories.

| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $27.3K | 12 | 21.9% |
| VENEZUELA | $26.5K | 9 | 21.3% |
| IRAQ | $24.5K | 2 | 19.6% |
| UZBEKISTAN | $24.0K | 6 | 19.2% |
| SPAIN | $17.1K | 6 | 13.7% |
| UNITED KINGDOM | $3.4K | 2 | 2.8% |
| GHANA | $2.0K | 1 | 1.6% |
Galaxy Super Speciality exports Sofosbuvir to 7 countries. The largest destination is NIGERIA accounting for 21.9% of Galaxy Super Speciality's Sofosbuvir shipments, followed by VENEZUELA (21.3%) and IRAQ (19.6%). These destinations reflect Galaxy Super Speciality's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | SPAIN | $30.7K | 13 |
| MIDAN PHARMA SCIENTIFIC BUREAU | IRAQ | $24.5K | 2 |
| IMDODI SHIFO LLC | UZBEKISTAN | $24.0K | 6 |
| HADDOCK PHARMA C.A AV VENEZUELA | VENEZUELA | $17.7K | 3 |
| GLOBAL AVIATION SERVICES CARGO | SPAIN | $6.6K | 2 |
| ARK OF GLO NIG LIMITED | NIGERIA | $6.2K | 1 |
India exported $18.1M worth of Sofosbuvir through 1,341 shipments from 150 suppliers to 113 countries, serving 377 buyers globally. Galaxy Super Speciality contributes $124.8K to this total, accounting for 0.3% of India's Sofosbuvir exports. Galaxy Super Speciality ships Sofosbuvir to 7 countries through 11 buyers.
Galaxy Super Speciality's average Sofosbuvir shipment value is $3.3K per consignment, based on 38 shipments totaling $124.8K. The largest destination is NIGERIA (21.9% of Galaxy Super Speciality's Sofosbuvir exports).
Galaxy Super Speciality ranks #11 among 150 Indian Sofosbuvir exporters with a 0.3% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($9.9M), HETERO LABS LIMITED ($5.3M), NATCO PHARMA LIMITED ($800.0K). Galaxy Super Speciality processed 38 shipments to 7 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VELAKAST- 28 TAB, SOFOSBUVIR 400MG + VELPATASVIR 100MG, BTC NO:1950006, MFG DT:12-2024, EXP DT: 11-2027 | $24.5K | 2 |
| VELAKAST- 28 TAB SOFOSBUVIR 400MG + VELPATASVIR 100MG B/N-1940082, MFG-10-2024,EXP-09-2027 | $14.1K | 7 |
| VELAKAST 28 TAB SOFOSBUVIR 400MG+VELPATASVIR 100 MG,BATCH 1903494 MANUFACTURING -07/2023 EXP-06/2026 | $13.3K | 1 |
| VELAKAST- 28 TAB SOFOSBUVIR 400MG + VELPATASVIR 100MG BATCH NO.1950006 MFG DT.12/2024,EXP DT.11/2027 | $10.3K | 2 |
| MYHEP DVIR SOFOSBUVIR 400 MG & DACLATASVIR 60MG B: 3183968 M: 06/2023 E: 04/2025 | $9.2K | 1 |
| VELAKAST- 28 TAB SOFOSBUVIR 400MG + VELP | $6.6K | 2 |
| VELAKAST - 28 TAB SOFOSBUVIR 400MG + VELPATASVIR 100MG B: 1903608 M: 11/2023E: 10/2026 | $6.3K | 1 |
| VELAKAST - 28 TAB SOFOSBUVIR 400MG + VEL |
What Galaxy Super Speciality must comply with to export Sofosbuvir to its top destination countries
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6β18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | ASPIDA LIFE SCIENCES PRIVATE LIMITED | $181.5K | 37 | 3 | $4.9K |
| 10 | LEOWIN HEALTHCARE LLP | $140.8K | 70 | 3 | $2.0K |
| 11 | GALAXY SUPER SPECIALITY β | $124.8K | 38 | 7 | $3.3K |
| 12 | PROSPERA LIFE SCIENCES PRIVATE LIMITED | $94.3K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 357 | 26.6% |
| SAHAR AIR | 269 | 20.1% |
| DELHI AIR CARGO ACC (INDEL4) | 158 | 11.8% |
| Bombay Air | 126 | 9.4% |
| DELHI AIR | 79 | 5.9% |
| AHEMDABAD AIR | 68 | 5.1% |
| AHEMDABAD AIR ACC (INAMD4) | 50 | 3.7% |
| HYDERABAD ACC (INHYD4) | 39 | 2.9% |
Galaxy Super Speciality also exports these antiviral & hiv medications products. Each links to the detailed product page.
Galaxy Super Speciality exports 7 products worth $240.3K. Beyond Sofosbuvir, top products include Velpatasvir, Olaparib, Axitinib, Cabozantinib, Ledipasvir. View the complete Galaxy Super Speciality profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Sofosbuvir β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Galaxy Super Speciality's Sofosbuvir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Galaxy Super Speciality
Full Company Profile β
7 products Β· $240.3K total trade Β· 3 categories
| E LIFE APEX PHARMACY COMPANY |
| NIGERIA |
| $3.6K |
| 3 |
| EV CARGO | UNITED KINGDOM | $3.4K | 2 |
| ARK OF GLO NIG LTD | NIGERIA | $3.4K | 1 |
| FARMAVILA C.A AV PRINCIPAL DE | VENEZUELA | $2.8K | 4 |
Galaxy Super Speciality supplies Sofosbuvir to 11 buyers globally. The largest buyer is TO THE ORDER OF (SPAIN), followed by MIDAN PHARMA SCIENTIFIC BUREAU (IRAQ) and IMDODI SHIFO LLC (UZBEKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $6.2K |
| 1 |
| VELAKAST 28 TAB SOFOSBUVIR 400MG VELPATASVIR 100MG BATCH NO 1950064 MFG DT 04 2025 EXP DT 03 2028 | $6.0K | 2 |
| VELAKAST-28 TAB SOFOSBUVIR 400MG +VELPAT | $5.1K | 2 |
Galaxy Super Speciality exports 25 distinct Sofosbuvir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VELAKAST- 28 TAB, SOFOSBUVIR 400MG + VELPATASVIR 100MG, BTC with 2 shipments worth $24.5K.
| 21 |
| 4 |
| $4.5K |
| 13 | DEVLIFE CORPORATION PRIVATE LIMITED | $91.7K | 3 | 1 | $30.6K |
Galaxy Super Speciality ranks #11 among 150 Indian Sofosbuvir exporters. Average shipment value of $3.3K compared to the market average of $120.8K. The closest competitors by value are ASPIDA LIFE SCIENCES PRIVATE LIMITED and LEOWIN HEALTHCARE LLP.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Galaxy Super Speciality.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sofosbuvir. For current shipment-level data, contact TransData Nexus.